SCHEMBL27995352

SCHEMBL27995352

NC(=O)CCC(O)C1CC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.41
PMP22 Q01453 2/20 0.41
KMT2A Q03164 2/20 0.41
ALOX15 P16050 1/20 0.41
TP53 P04637 1/20 0.37
KDM4E B2RXH2 1/20 0.35
GMNN O75496 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX5 P09917 1/20 0.33
TARDBP Q13148 1/20 0.32
EPHX1 P07099 2/20 0.32
DPP4 P27487 1/20 0.31
DPP8 Q6V1X1 1/20 0.31
DPP9 Q86TI2 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693791 0.90 TP53 (0.52) BLMPMP22KMT2AALOX15TP53
SCHEMBL29954549 0.79 TET2 (0.46) LMNAMAPTCYP1A2
SCHEMBL15776270 0.76
SCHEMBL29616703 0.76 KMT2A (0.40) BLMPMP22KMT2AALOX15ALOX5
SCHEMBL22595358 0.74 ALOX15 (0.48) BLMPMP22KMT2AALOX15ALOX5
SCHEMBL7384390 0.71 ALOX15 (0.33) BLMPMP22KMT2AALOX15
SCHEMBL9506053 0.71 ALOX15 (0.33) BLMPMP22KMT2AALOX15
SCHEMBL5673417 0.71 ALOX15 (0.36) BLMPMP22KMT2AALOX15ALOX5
SCHEMBL23704649 0.70
SCHEMBL15415082 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104250233-B A kind of preparation method of 4-tertbutyloxycarbonyl-2-cyclopropyl morpholine HUNAN HUATENG PHARMACEUTICAL Co.,Ltd. (CN) 2016-03-16 CN disclosed
CN-104250233-A 4-tert-butyloxycarboryl-2-cyclopropyl morpholine preparation method Hunan huateng pharmaceutical co ltd 2014-12-31 CN disclosed